Braveheart
3 known investors
Braveheart develops treatments for hypertrophic cardiomyopathy and related cardiac conditions. The company focuses on improving the standard of care for patients with these disease types.
Investors · 3
In the news
- Wonder Raises $650M Series D at $9B Valuation — Food & Beverage Magazinefb101.com · 2026
- Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · 2026
- Seeds | Jumps to World Model Unicorn in One Year! Manifold AI Raises Hundreds of Millions in New Funding | Gasgooautonews.gasgoo.com · 2026
- Fei-Fei Li's World Labs Raises $1B in Fresh Funding to Advance Development of World Modelstheaiinsider.tech · 2026